Amdocs (NASDAQ:DOX) Issues Q2 2025 Earnings Guidance

Amdocs (NASDAQ:DOX) updated its second quarter 2025 earnings guidance on Tuesday. The company provided earnings per share guidance of 1.670-1.730 for the period, compared to the consensus earnings per share estimate of 1.710. The company issued revenue guidance of $1.1 billion-$1.1 billion, compared to the consensus revenue estimate of $1.1 billion. Amdocs also updated its FY 2025 guidance to 6.859-7.116 EPS.

Amdocs Trading Down 0.6 %

NASDAQ:DOX traded down $0.53 during mid-day trading on Tuesday, reaching $86.86. 1,254,157 shares of the company’s stock traded hands, compared to its average volume of 572,121. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.20 and a quick ratio of 1.20. The company has a 50 day moving average price of $85.96 and a 200-day moving average price of $86.40. The firm has a market capitalization of $9.81 billion, a price-to-earnings ratio of 20.49, a PEG ratio of 1.47 and a beta of 0.71. Amdocs has a 12-month low of $74.41 and a 12-month high of $94.04.

Amdocs (NASDAQ:DOX) last announced its earnings results on Tuesday, February 4th. The technology company reported $1.45 earnings per share for the quarter, missing analysts’ consensus estimates of $1.64 by ($0.19). Amdocs had a net margin of 9.85% and a return on equity of 18.69%. On average, sell-side analysts predict that Amdocs will post 6.19 earnings per share for the current year.

Amdocs Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st were issued a dividend of $0.479 per share. The ex-dividend date of this dividend was Tuesday, December 31st. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.21%. Amdocs’s dividend payout ratio (DPR) is 45.28%.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on DOX shares. StockNews.com cut Amdocs from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, January 14th. Oppenheimer upped their target price on shares of Amdocs from $98.00 to $105.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 13th. Finally, Barclays decreased their price target on shares of Amdocs from $113.00 to $111.00 and set an “overweight” rating for the company in a research note on Thursday, November 14th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Amdocs currently has an average rating of “Moderate Buy” and a consensus price target of $101.20.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.